If you're in Berlin at #ICPE2024, be sure to stop by exhibit booth 901, chat with our experts, and learn about some of our latest research. Check out our list of presentations at buff.ly/4fWYs57 #ICPE24 #epidemiology #pharmacoepidemiology #healthcaredata

In the first of our new how-to series, we explore the importance of understanding burden of illness and unmet need, as well as giving an overview of the key considerations when conducting reviews. Want to know more? Download the guide: buff.ly/3yVPVP0 #BOI #HEOR #HTA

Don't miss the poster currently on display at #ICPE2024, Characteristics of Patients with ATTR Amyloidosis and Methodological Approaches for Establishing Clinical Subtype in the Netherlands. #epidemiology #pharmacoepidemiology #amyloidosis #ATTR

Today is the final day of the ICPE 2024 annual meeting! If you haven't already, be sure to stop by booth 901 before the exhibit hall closes and connect with our colleagues! #ICPE24 #epidemiology #pharmacoepidemiology #healthcaredata

In this first instalment of "Drill Down & Catch Up", learn about the latest breakthroughs in neuroscience and how they could revolutionize the way we treat psychiatric disorders. Read now: buff.ly/476UEdi #Neuroscience #Neurology #PsychiatricDisorders

Heading into the 2024 Paralympics, Ellie Challis is now flying two flags, one from her home country, the UK, and the Meningitis Flag, the symbol rallying the meningitis community to end this disease whilst showing her victory against meningitis when she was a baby! 💛💜💙

If you're at the #ESCCongress this weekend, be sure to catch our on-site staff! E-mail [email protected] to schedule a meeting with us. buff.ly/3yKCHVy #cardiology #ESC2024 #CardiovascularHealth #Cardiovascular #Patients

#ICPE2024Annual was filled with insightful sessions focused on the critical area of data quality and governance, as well as fit-for-purpose assessments conducted based on these crucial aspects. buff.ly/3z7rXjW #dataquality #AI #innovation #learning #pharmacoepidemiology

The 1st episode of our integrated evidence generation planning (IEGP) podcast miniseries with the Medical Affairs Professional Society and HE-HTA and RWE perspectives is live! buff.ly/3Xel4pe #IEGP #IntegratedEvidenceGenerationPlanning #MAPS #MedAffairs #MedicalAffairs

Download our guide to explore the benefits and best practices for integrating #qualitativeinterviews into your #clinicaltrial protocol with embedded #patient interviews! buff.ly/4cT3Ovi #PatientCenteredOutcomes #OutcomesResearch #HEOR #HTA #PCO #PatientVoice

Read our latest article, “GP consultations for menstrual disorders after COVID-19 vaccination – A self-controlled cohort study based on routine healthcare data from the Netherlands,” at buff.ly/3XnshEI #PeerReviewedArticle #Vaccine #RWD #RWE #COVID19 #HealthcareData

Check out the webinar, "At What Cost? Patient Impacts & Policy Imperatives Related to the IRA," and learn about the #IRA’s potential unintended consequences to #patienthealth and what can be done to mitigate these risks. buff.ly/4g1W1hz #PolicyImpact #MedicalResearch

The Spanish Ministry of Health has launched the Draft Royal Decree, a game-changer for the healthcare industry in Spain, and setting the stage for a new framework governing Health Technology Assessments (#HTAs). Learn more at buff.ly/3ANwjNU #EUHTA #HEOR #HTARegulation

Our staff attended the recent European Society of Cardiology Congress, featuring cutting-edge research and practice-enhancing science in cardiology. Check out our takeaways at buff.ly/3AZFRFk #ESCCongress2024 #ESC #Cardiology #CardiovascularDisease #CardiovascularCare

Lumanity will be delivering the opening keynote on the future of #lifescience #technology and #innovation at #IPLS2024 next week. Reach out to [email protected] to meet on-site. Learn more at buff.ly/3Tq9Xbx #LifeScienceConsulting #TechnologyAndInnovation #Pharma

#Dementia affects a huge number of people directly and indirectly in Scotland. We worked on a campaign with the Scottish government, committed to addressing the stigma around the early stages when a person is first diagnosed. Watch #RethinkDementia at buff.ly/4ecu4C3

Calling all rare disease stories! Submit your unique, rare disease experiences to our '29 stories' initiative through a series of quick and insightful questions at buff.ly/3Tkn6D3 #raredisease #rarediseases #patientengagement #rarecondition #shareyourstory

Will you be at RESI Boston Sept. 25 as part of #BostonBiotechWeek? If so, be sure to catch “Funding and Accelerating Early-Stage Innovations for Neuromuscular Diseases” from 9:00-9:50am. E-mail [email protected] to meet on-site. #RESI2024 #Biotech #NeuromuscularDiseases

If you're at the European Society for Medical Oncology (ESMO) Congress in Barcelona, be sure to reach out and connect with our staff while on-site! #ESMO24 #Oncology #cancerresearch #cancer #ESMO #pharma #biotech

Lumanity will be delivering the opening keynote on the future of #lifescience #technology and #innovation at #IPLS2024 next week. Reach out to [email protected] to meet on-site. Learn more at buff.ly/3B1MZBl #LifeScienceConsulting #TechnologyAndInnovation #Pharma